Skip Navigation
Skip to contents

Ann Coloproctol : Annals of Coloproctology

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > Ann Coloproctol > Volume 42(5); 2026 > Article
Original Article
ERAS
Wearable-measured early postoperative mobility is associated with recovery after elective colorectal cancer surgery: a prospective pilot study
Hyo Jun Kim1orcid, Min Jung Kim1,2orcid, Youngjin Kim1orcid, Hyun Tae Lim1orcid, Jae Hyun Park1orcid, Jesung Park1orcid, Ji Won Park1,2orcid, Seung-Bum Ryoo1,2orcid, Seung-Yong Jeong1,2orcid, Kyu Joo Park1orcid
Annals of Coloproctology 2026;42(5):553-560.
DOI: https://doi.org/10.3393/ac.2026.00619.0088
Published online: October 27, 2026

1Department of Surgery, Seoul National University College of Medicine, Seoul, Korea

2Seoul National University Cancer Research Institute, Seoul, Korea

Correspondence to: Min Jung Kim, MD, PhD Department of Surgery, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Korea Email: minjungkim@snuh.org
• Received: May 7, 2026   • Revised: June 24, 2026   • Accepted: July 8, 2026

© 2026 The Korean Society of Coloproctology

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

prev next
  • 893 Views
  • 15 Download
  • Purpose
    Early mobilization is a key component of Enhanced Recovery After Surgery (ERAS) pathways following colorectal cancer surgery; however, objective postoperative mobility quantification remains limited. We evaluated whether early postoperative step counts measured using a wearable device could be associated with the achievement of ERAS-based discharge eligibility.
  • Methods
    In this prospective pilot study, adults undergoing elective colorectal cancer resection at a single tertiary academic referral hospital wore a consumer wearable device (Galaxy Watch 5) from the day of surgery. Cumulative step counts on postoperative days (PODs) 1 and 2 were recorded. Discharge readiness was assessed daily by predefined ERAS criteria. The patients were dichotomized according to the median cumulative step count (3,781 steps). The primary endpoint was the achievement of ERAS-based discharge eligibility by POD 3, and the secondary endpoints included time to discharge readiness and postoperative length of stay.
  • Results
    Between August 2023 and December 2024, 38 patients were evaluated. Discharge readiness by POD 3 was more frequent in the active group (68.4% vs. 26.3%; odds ratio, 6.07; 95% confidence interval, 1.49–24.76; P=0.009), which achieved discharge readiness earlier (median, POD 3 vs. POD 4; P=0.003) and had a shorter postoperative stay (median, 5 days vs. 6 days; P=0.041) than did the inactive group. Early diet tolerance differed between the groups (P=0.013).
  • Conclusion
    Higher early postoperative step counts were associated with earlier ERAS-based discharge readiness and shorter hospitalization. Wearable-derived mobility might provide an objective marker of recovery and target for postoperative mobilization strategies.
The initial draft of this graphical abstract was generated using generative artificial intelligence. It was subsequently reviewed, revised, and confirmed by the authors, editors, and publisher to ensure its accuracy and consistency with the content of the article.
Colorectal cancer remains a major contributor to the global cancer burden and continues to impose substantial morbidity and mortality worldwide [1, 2]. Curative-intent surgical resection is central to the treatment of localized disease; however, postoperative recovery following colorectal resection is heterogeneous and may be complicated by delayed functional recovery, prolonged hospitalization, and postoperative morbidity. These factors collectively increase patient burden and healthcare resource utilization [3, 4].
Enhanced Recovery After Surgery (ERAS) pathways were developed to standardize evidence-based perioperative care and accelerate recovery through multimodal interventions, including optimized analgesia, early oral intake, and early mobilization. In patients undergoing colorectal surgery, ERAS implementation has been associated with shorter length of stay and reduced complication rates without compromising safety [4–6]. Among ERAS components, early mobilization is consistently emphasized because it supports the restoration of physiological function and functional independence, which are key determinants of readiness for discharge [3, 4, 7, 8].
Despite its central importance, postoperative mobilization is often documented inconsistently in routine care, which limits objective assessment of adherence and early recovery trajectories. Consumer wearables and mobile health technologies enable continuous, time-stamped quantification of physical activity, providing an opportunity for capturing mobility as an objective recovery metric and supporting postoperative care through monitoring and feedback [9–14].
In patients undergoing elective colorectal cancer surgery, evidence remains limited regarding how early postoperative mobility, as quantified by a wearable device, relates to standardized ERAS-based discharge readiness endpoints. Therefore, in this study, we aimed to evaluate the association between step counts recorded during postoperative days (PODs) 1 and 2 using a wearable device and achievement of ERAS-based discharge eligibility following elective colorectal cancer resection.
Ethics statement
This study was approved by the Institutional Review Board of Seoul National University Hospital (No. 2212-022-1383). Written informed consent was obtained from all participants. Data were deidentified prior to analysis. The study was conducted in accordance with the principles of the Declaration of Helsinki. Clinical trial registration was not applicable because this was a prospective observational study without investigator-assigned therapeutic or behavioral interventions.
Study design, setting, and participants
This prospective pilot study was conducted at a single tertiary academic referral hospital and enrolled consecutive patients undergoing elective resection for colorectal cancer between August 2023 and December 2024. Eligible participants were adults aged 18 years or older who were scheduled to undergo primary abdominal resection for colorectal cancer. The inclusion criteria included an Eastern Cooperative Oncology Group performance status of 0–2 and an American Society of Anesthesiologists (ASA) physical status of I–III. Patients were excluded if they declined participation or were unwilling or unable to comply with postoperative use of the wearable device.
Wearable device and postoperative mobility assessment
The participants were provided with a wearable device (Galaxy Watch 5 SM R900, Samsung Electronics) from the day of surgery. Step counts were recorded on PODs 1 and 2. The primary mobility exposure was defined as the cumulative step count across PODs 1 and 2, in accordance with the prespecified grouping strategy.
ERAS-based discharge readiness assessment
Discharge readiness was assessed daily by predefined ERAS-based criteria. Readiness was defined as the first POD on which all prespecified criteria were fulfilled: (1) afebrile status; (2) tolerance of a soft or regular diet; (3) absence of nausea or vomiting; (4) passage of flatus or bowel movement; (5) ability to ambulate for at least 1 hour per day; (6) no evidence of surgical site infection; (7) pain controlled to a numeric rating scale score of <4 with oral analgesics; and (8) absence of surgery-related complications, as determined by the attending surgeon. The 8 ERAS-based discharge readiness criteria were constructed specifically for the present study and were prospectively applied as a standardized research assessment to patients enrolled in this ERAS study cohort. They do not represent a formal discharge checklist routinely applied to all patients in daily clinical practice at our institution.
Covariates and perioperative variables
Demographic and perioperative variables, including age, sex, body mass index (BMI), ASA physical status, tumor location, surgical approach, and procedure type, were prospectively collected from electronic medical records. Postoperative outcomes, including complications and readmission, were recorded during the index admission and the follow-up period, as defined in the institutional clinical workflow.
Outcomes and group definitions
The primary endpoint was the achievement of ERAS-based discharge readiness by POD 3. The secondary endpoints included time to discharge readiness, actual postoperative length of stay, and achievement of individual ERAS criteria during the early postoperative period. The patients were dichotomized into an “active” group and an “inactive” group according to the cohort median cumulative step count for PODs 1 and 2 (active, ≥3,781 steps; inactive, <3,781 steps).
Statistical analysis
Continuous variables are summarized as mean±standard deviation or median (range), as appropriate, and categorical variables as number (percentage). Between-group comparisons were performed using the independent t-test or Mann-Whitney U-test for continuous variables, and the chi-square test or Fisher exact test for categorical variables, depending on data distribution and expected cell counts.
Time to discharge readiness was summarized as the observed median (range) and compared between groups using the Mann-Whitney U-test. Effect sizes for the primary endpoint were additionally expressed as odds ratios (ORs) with 95% confidence intervals (CIs). A 2-sided P-value of <0.05 was considered statistically significant. Analyses were performed using IBM SPSS ver. 25 (IBM Corp) and R ver. 4.1.2 (R Foundation for Statistical Computing).
To evaluate the potential influence of exclusion due to insufficient wearable data, baseline characteristics were compared between patients included in the final analysis and those excluded from the final analysis. A multivariable logistic regression model was used to assess the adjusted association between early postoperative mobility group and discharge eligibility by POD 3, with adjustment for age, sex, BMI category, and ASA physical status. Exploratory subgroup analyses were performed according to age, sex, BMI category, ASA physical status, tumor location, pathological stage, and stoma formation; interaction terms between mobility group and each subgroup variable were tested to evaluate heterogeneity across subgroups.
Patient cohort and baseline characteristics
Between August 2023 and December 2024, 38 patients were included in the study and were dichotomized according to the cohort median cumulative step count across PODs 1 and 2 (active, n=19; inactive, n=19) (Fig. 1). Among the 76 enrolled patients, baseline characteristics were comparable between the 38 patients included in the final analysis and the 38 patients excluded from the final analysis due to withdrawal or insufficient wearable data (all P>0.05) (Supplementary Table 1). Baseline demographic, clinicopathological, and operative characteristics were broadly balanced between the groups. Although the inactive group tended to be older than the active group (median age, 66 years vs. 58 years), this difference did not reach statistical significance (P=0.125). Sex distribution was identical between the active and inactive groups, and BMI category, ASA physical status, tumor location, surgical approach, procedure type, and pathological stage were also comparable between the groups (all P>0.05) (Table 1). Postoperative morbidity was similar (complications, 15.8% vs. 21.1%; P>0.999), and readmission was infrequent (5.3% vs. 0%, P>0.999). The single readmitted patient belonged to the active group and presented to the emergency department 6 days after discharge with abdominal pain; abdominal computed tomography showed adhesive ileus, leading to readmission for management.
Association between early step counts and ERAS-based discharge readiness
The active group achieved ERAS-defined discharge readiness earlier than did the inactive group (median, POD 3 [range, POD 2–7] vs. POD 4 [range, POD 3–16]; P=0.003) (Table 2). A greater proportion of patients in the active group achieved discharge readiness by POD 3 (68.4% vs. 26.3%, P=0.009) (Fig. 2). This corresponded to an OR of 6.07 (95% CI, 1.49–24.76) and a risk ratio of 2.60 (95% CI, 1.15–5.86) for discharge readiness by POD 3 in the active compared with the inactive group. In multivariable logistic regression adjusted for age, sex, BMI category, and ASA physical status, the active group remained significantly associated with discharge eligibility by POD 3 (adjusted OR, 5.55; 95% CI, 1.23–25.02; P=0.026) (Table 3). Among the individual ERAS-based discharge criteria assessed by POD 3, intolerance of diet was the only criterion that differed significantly between groups, occurring more frequently in the inactive group than in the active group (52.6% vs. 10.5%, P=0.013). In contrast, the ambulation criterion (ambulation for at least 1 hour per day) was rarely unmet and showed no significant between-group difference (0% vs. 5.3%, P>0.999). All other criteria were comparable between the groups (all P>0.05) (Table 4).
Exploratory subgroup analyses showed a generally consistent direction of association between the active group and discharge eligibility by POD 3 across age, sex, BMI category, ASA physical status, tumor location, pathological stage, and stoma formation. No statistically significant interaction was observed in any subgroup analysis (all P for interaction >0.05) (Supplementary Table 2), although the estimates should be interpreted cautiously because of the small sample size and wide CIs.
Postoperative length of stay
Consistent with earlier discharge readiness, the active group had a shorter postoperative hospital stay (median, 5 days [range, 4–8 days] vs. 6 days [range, 4–16 days]; P=0.041) (Table 2).
In this prospective pilot study of patients undergoing elective colorectal cancer resection within an ERAS pathway, higher levels of early postoperative mobility, as quantified by a wearable device, were associated with faster attainment of ERAS-based discharge readiness and a shorter postoperative hospital stay. Approximately two-thirds of patients in the higher-mobility group achieved discharge readiness by POD 3 compared with around one-quarter in the lower-mobility group, and the median time to readiness was one day shorter. Notably, early tolerance of a soft or regular diet differed between the groups, whereas postoperative complications and readmissions were similar. These results suggested that early mobility was more strongly associated with endpoints related to bowel function recovery than with short-term safety outcomes.
The present findings reinforced the central role of early mobilization within ERAS care and extended the existing literature by providing an objective, time-stamped mobility metric linked to a standardized recovery endpoint. The ERAS guidelines for colorectal surgery consistently emphasize early mobilization and multimodal recovery components, and ERAS implementation has been associated with shorter length of stay and improved outcomes across a range of settings [3, 4, 15]. However, adherence to individual ERAS elements, particularly mobilization, can be difficult to quantify reliably in routine clinical practice. Large registry-based and multicenter cohort studies have shown that higher ERAS protocol compliance is associated with improved postoperative outcomes, highlighting the value of objective and auditable recovery measures that may strengthen implementation efforts [16, 17].
Our results are consistent with those in previous perioperative wearable studies suggesting that digitally measured ambulation is clinically meaningful and is often underappreciated in standard documentation. In one cohort study, wearable activity monitors improved the assessment of daily ambulation, and early postoperative step count, particularly on POD 1, was associated with the likelihood of shorter length of stay [18]. In patients undergoing colorectal surgery, wearable research has frequently focused on preoperative activity and risk prediction. For instance, 1 study used wearable monitoring to evaluate the relationship between baseline activity and postoperative outcomes in elective colorectal surgery [14]. In contrast, the present study focuses on the immediate postoperative period and links step counts to an ERAS-based discharge readiness endpoint, which is less susceptible than raw length of stay to nonmedical delays in discharge.
Several mechanisms could plausibly link early postoperative mobility to earlier discharge readiness. Mobilization might support pulmonary function, reduce the risk of venous thromboembolism, and attenuate deconditioning following major abdominal surgery. A systematic review evaluating early mobilization protocols after abdominal and thoracic surgery summarized evidence that structured mobilization programs can influence postoperative outcomes, although substantial heterogeneity across protocols remains [19]. The observed between-group difference in early diet tolerance is also biologically and clinically plausible. Ambulation and increased upright time may be associated with earlier resumption of oral intake and improved functional recovery. At the same time, reverse causality cannot be excluded; patients with less pain, nausea, fatigue, or early ileus may simply be able to mobilize more. From an implementation perspective, either interpretation supports the use of wearable step counts as a pragmatic early marker of recovery trajectory, capturing multiple aspects of postoperative well-being in a low-burden manner. The significant difference in diet tolerance suggests that early postoperative step counts may partly reflect gut-function recovery and the absence of ileus, pain, nausea, or abdominal discomfort. However, the ambulation criterion used in the composite discharge readiness endpoint was a broad binary threshold intended to identify patients with markedly insufficient ambulation, whereas wearable-derived step counts provided objective and quantitative information on mobility among patients who met this minimum requirement. Thus, step counts may offer more granular information than conventional clinical ambulation criteria and may serve as an integrated marker of early postoperative recovery, reflecting both functional mobility and recovery of oral intake and gastrointestinal function.
Beyond measurement, wearable-derived mobility offers a pathway to more actionable care. Step count trajectories could be incorporated into ERAS auditing and bedside decision support to identify patients at risk of delayed recovery and trigger targeted interventions, such as intensified physiotherapy, optimization of multimodal analgesia and antiemetic strategies, earlier removal of lines or tubes, or structured step goals aligned with patient capacity. The potential for digital tools to support recovery is reinforced by randomized evidence in abdominal surgery. A personalized perioperative eHealth program improved return to normal activities in one trial, and a subsequent multicenter trial evaluated personalized eHealth support following major abdominal surgery [11, 12]. In addition, a meta-analysis reported that mobile health technology for remote home monitoring after surgery is feasible and has been examined in relation to recovery outcomes [13]. Taken together, wearable mobility metrics may represent a scalable component of “digital ERAS,” spanning both in-hospital recovery and postdischarge monitoring.
This study has some limitations. First, the sample size was small and derived from a single center, which limits both precision and generalizability. Second, incomplete wearable data resulted in a reduced analysis set, raising the possibility of selection bias. However, measured baseline characteristics were comparable between patients included in and excluded from the final analysis. Third, the activity threshold was defined according to the cohort median, which is reasonable in a pilot context but does not necessarily represent a transferable clinical cutoff across institutions, patient populations, or devices. Fourth, although a multivariable model adjusting for age, sex, BMI category, and ASA physical status was added, the number of outcome events was limited; therefore, overfitting and residual confounding related to baseline functional status, operative complexity, pain control, and postoperative symptoms remain possible. Fifth, device wear time and adherence were not systematically quantified. Sixth, step count measurement validity in the immediate postoperative setting should be interpreted with caution. Consumer wrist-worn devices, including the Galaxy Watch 5 used in this study, have not been specifically validated for the low-cadence, slow, shuffling gait that is typical of early postoperative ambulation; therefore, systematic step undercounting during slow ambulation is possible. Seventh, as the discharge readiness definition includes an ambulation criterion, conceptual overlap with step count is possible. Future studies should therefore prespecify sensitivity analyses using discharge readiness definitions that exclude mobility criteria or incorporate complementary endpoints. Finally, length of stay might be influenced by complications and institutional practice patterns. Although the use of discharge readiness mitigates some nonmedical delay, system-level factors might still affect the timing of discharge [20].
Future research should validate these findings in larger multicenter cohorts with prespecified analytic plans, including continuous modeling of step counts rather than dichotomization, and appropriate adjustment for key confounders. Establishing actionable step count targets and determining whether wearable-informed mobilization interventions can causally improve recovery will require interventional trials. In parallel, integration of additional wearable-derived signals, such as heart rate trends and sleep metrics, with patient-reported outcomes may enable more granular recovery phenotyping and earlier detection of deviations from expected recovery trajectories. Emerging evidence, including high-impact studies using consumer wearables to characterize postoperative recovery patterns, highlights the broader potential of wearable-derived digital biomarkers in surgical care [21].
In conclusion, higher early postoperative step counts captured using a wearable device were associated with earlier ERAS-based discharge readiness following elective colorectal cancer surgery. Wearable-derived step counts may serve as objective, scalable, and granular markers of early postoperative recovery, reflecting both functional mobility and gut-function recovery; however, these observational findings should be interpreted as associations rather than proof that mobilization itself directly caused earlier discharge readiness.

Conflict of interest

Min Jung Kim is an associate editor of this journal, but was not involved in the peer reviewer selection, evaluation, or decision process of this article. No other potential conflict of interest relevant to this article was reported.

Funding

This study was supported by the National R&D Program for Cancer Control through the National Cancer Center (NCC), funded by the Korean Ministry of Health and Welfare (No. RS-2023-CC140354).

Author contributions

Conceptualization: HJK, MJK, SYJ; Data curation: HJK; Formal analysis: HJK; Funding acquisition: SYJ; Investigation: all authors; Methodology: HJK, MJK, SYJ; Project administration: HJK, MJK; Supervision: all authors; Writing–original draft: HJK; Writing–review & editing: all authors. All authors read and approved the final manuscript.

Supplementary Table 1.

Clinicopathological characteristics by final analysis inclusion status
ac-2026-00619-0088-Supplementary-Table-1.pdf

Supplementary Table 2.

Subgroup analysis of the association between early postoperative step count group and discharge eligibility by POD 3
ac-2026-00619-0088-Supplementary-Table-2.pdf
Supplementary materials are available from https://doi.org/10.3393/ac.2026.00619.0088.
Fig. 1.
Study flow diagram of patient enrollment, postoperative wearable data collection, and final group allocation. POD, postoperative day.
ac-2026-00619-0088f1.jpg
Fig. 2.
Early postoperative step counts and discharge eligibility by postoperative day (POD) 3. Proportion of patients achieving Enhanced Recovery After Surgery (ERAS)-based discharge eligibility by POD 3 according to early postoperative mobility (POD 1–2 cumulative steps: active group, ≥3,781 steps; inactive group, <3,781). The P-value was calculated using the chi-square test.
ac-2026-00619-0088f2.jpg
ac-2026-00619-0088f3.jpg
Table 1.
Clinicopathological characteristics according to early postoperative step counts (n=38)
Characteristic Active group (n=19) Inactive group (n=19) P-value
Age (yr) 58 (24–81) 66 (45–73) 0.125
Sex >0.999
 Male 13 (68.4) 13 (68.4)
 Female 6 (31.6) 6 (31.6)
BMI (kg/m2) 0.295
 ≤25 11 (57.9) 15 (78.9)
 >25 8 (42.1) 4 (21.1)
ASA physical status >0.999
 Ⅰ 2 (10.5) 2 (10.5)
 Ⅱ 15 (78.9) 15 (78.9)
 Ⅲ 2 (10.5) 2 (10.5)
Tumor location 0.719
 Right-sided colon 4 (21.1) 5 (26.3)
 Left-sided colon 10 (52.6) 11 (57.9)
 Rectum 5 (26.3) 3 (15.8)
Surgical approach 0.368
 Laparoscopic 18 (94.7) 18 (94.7)
 Open 0 (0) 1 (5.3)
 Conversion to open 1 (5.3) 0 (0)
Procedure type 0.699
 Right hemicolectomy 4 (21.1) 3 (15.8)
 Transverse colectomy 0 1 (5.3)
 Left hemicolectomy 1 (5.3) 2 (10.5)
 Anterior resection 7 (36.8) 9 (47.4)
 Low anterior resection 5 (26.3) 4 (21.1)
 Ultralow anterior resection 1 (5.3) 0 (0)
 Abdominoperineal resection 1 (5.3) 0 (0)
Pathological stage 0.598
 Ⅰ 6 (31.6) 6 (31.6)
 Ⅱ 3 (15.8) 5 (26.3)
 Ⅲ 5 (26.3) 6 (31.6)
 Ⅳ 5 (26.3) 2 (10.5)
Postoperative complication 3 (15.8) 4 (21.1) >0.999
 Ileus 2 (10.5) 1 (5.3)
 Urinary complication 1 (5.3) 1 (5.3)
 Wound complication 0 (0) 1 (5.3)
 Fluid collection 0 (0) 1 (5.3)
Time to passage of flatus or stool (day) 1 (1–3) 2 (1–4) 0.581
Readmission 1 (5.3) 0 (0) >0.999

Values are presented as number (%) or median (range).

BMI, body mass index; ASA, American Society of Anesthesiologists.

Table 2.
Association between cumulative step count on PODs 1 and 2 measured using a wearable device and discharge eligibility (n=38)
Active group (n=19) Inactive group (n=19) P-value
Discharge eligibility (day) 3 (2–7) 4 (3–16) 0.003
 Within POD 2 2 (10.5) 0 (0) 0.486
 Within POD 3 13 (68.4) 5 (26.3) 0.009
 Within POD 4 17 (89.5) 11 (57.9) 0.062
 Within POD 5 18 (94.7) 13 (68.4) 0.090
Postoperative length of stay (day) 5 (4–8) 6 (4–16) 0.041

Values are presented as observed median (range) or number (%). The P-value for time to discharge readiness was calculated using the Mann-Whitney U-test. All 38 patients achieved discharge readiness during the observation period; no observations were censored.

POD, postoperative day.

Table 3.
Multivariable logistic regression analysis for ERAS-based discharge eligibility by POD 3
Variable Adjusted OR (95% CI) P-value
Active group (vs. inactive group) 5.55 (1.23–25.02) 0.026
Age (per 1-yr increase) 0.98 (0.90–1.06) 0.577
Sex (male vs. female) 1.04 (0.20–5.35) 0.959
BMI (>25 kg/m2 vs. ≤25 kg/m2) 1.94 (0.37–10.30) 0.436
ASA physical status (III vs. I–II) 5.12 (0.31–84.83) 0.254

ERAS, Enhanced Recovery After Surgery; POD, postoperative day; BMI, body mass index; ASA, American Society of Anesthesiologists.

Table 4.
Comparison of individual unmet ERAS-based discharge criteria by POD 3 between active and inactive groups (n=38)
Discharge eligibility criteria No. of patients (%) P-value
Active group (n=19) Inactive group (n=19)
Afebrile status 0 (0) 3 (15.8) 0.230
Tolerance of diet 2 (10.5) 10 (52.6) 0.013
Absence of nausea or vomiting 0 (0) 4 (21.1) 0.105
Passage of flatus or stool 0 (0) 1 (5.3) >0.999
Ambulation for at least 1 hr per day 0 (0) 1 (5.3) >0.999
Absence of surgical site infection 0 (0) 1 (5.3) >0.999
Adequate pain control (NRS <4) 3 (15.8) 6 (31.6) 0.447
Absence of surgery-related complications 1 (5.3) 4 (21.1) 0.340

ERAS, Enhanced Recovery After Surgery; POD, postoperative day; NRS, numeric rating scale.

  • 1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024;74:229–63. ArticlePubMedPMC
  • 2. Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut 2023;72:338–44. Article
  • 3. Gustafsson UO, Rockall TA, Wexner S, How KY, Emile S, Marchuk A, et al. Guidelines for perioperative care in elective colorectal surgery: Enhanced Recovery After Surgery (ERAS) Society recommendations 2025. Surgery 2025;184:109397.ArticlePubMed
  • 4. Ljungqvist O, Scott M, Fearon KC. Enhanced Recovery After Surgery: a review. JAMA Surg 2017;152:292–8. Article
  • 5. Fearon KC, Ljungqvist O, Von Meyenfeldt M, Revhaug A, Dejong CH, Lassen K, et al. Enhanced Recovery After Surgery: a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr 2005;24:466–77. ArticlePubMed
  • 6. Varadhan KK, Neal KR, Dejong CH, Fearon KC, Ljungqvist O, Lobo DN. The Enhanced Recovery After Surgery (ERAS) pathway for patients undergoing major elective open colorectal surgery: a meta-analysis of randomized controlled trials. Clin Nutr 2010;29:434–40. ArticlePubMed
  • 7. Basse L, Hjort Jakobsen D, Billesbølle P, Werner M, Kehlet H. A clinical pathway to accelerate recovery after colonic resection. Ann Surg 2000;232:51–7. ArticlePubMedPMC
  • 8. Kehlet H, Wilmore DW. Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg 2008;248:189–98. ArticlePubMed
  • 9. Knight SR, Ng N, Tsanas A, McLean K, Pagliari C, Harrison EM. Mobile devices and wearable technology for measuring patient outcomes after surgery: a systematic review. NPJ Digit Med 2021;4:157.ArticlePubMedPMCPDF
  • 10. Sun V, Xiao Y, Li S, Palmer J, Tribby CP, Crane TE, et al. Comparative effectiveness of remote perioperative telemonitoring in cancer surgery: a randomized trial. NPJ Digit Med 2025;8:555.ArticlePubMedPMCPDF
  • 11. van der Meij E, Anema JR, Leclercq WK, Bongers MY, Consten EC, Schraffordt Koops SE, et al. Personalised perioperative care by e-health after intermediate-grade abdominal surgery: a multicentre, single-blind, randomised, placebo-controlled trial. Lancet 2018;392:51–9. ArticlePubMed
  • 12. den Bakker CM, Schaafsma FG, Consten EC, Schraffordt Koops SE, van der Meij E, van de Ven PM, et al. Personalised electronic health programme for recovery after major abdominal surgery: a multicentre, single-blind, randomised, placebo-controlled trial. Lancet Digit Health 2023;5:e485–94. ArticlePubMed
  • 13. Dawes AJ, Lin AY, Varghese C, Russell MM, Lin AY. Mobile health technology for remote home monitoring after surgery: a meta-analysis. Br J Surg 2021;108:1304–14. ArticlePubMedPDF
  • 14. Hedrick TL, Hassinger TE, Myers E, Krebs ED, Chu D, Charles AN, et al. Wearable technology in the perioperative period: predicting risk of postoperative complications in patients undergoing elective colorectal surgery. Dis Colon Rectum 2020;63:538–44. ArticlePubMed
  • 15. Gustafsson UO, Scott MJ, Hubner M, Nygren J, Demartines N, Francis N, et al. Guidelines for perioperative care in elective colorectal surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations: 2018. World J Surg 2019;43:659–95. ArticlePubMed
  • 16. ERAS Compliance Group. The impact of enhanced recovery protocol compliance on elective colorectal cancer resection: results from an international registry. Ann Surg 2015;261:1153–9. ArticlePubMed
  • 17. Ripollés-Melchor J, Ramírez-Rodríguez JM, Casans-Francés R, Aldecoa C, Abad-Motos A, Logroño-Egea M, et al. Association between use of Enhanced Recovery After Surgery protocol and postoperative complications in colorectal surgery: the Postoperative Outcomes Within Enhanced Recovery After Surgery Protocol (POWER) Study. JAMA Surg 2019;154:725–36. ArticlePubMedPMC
  • 18. Daskivich TJ, Houman J, Lopez M, Luu M, Fleshner P, Zaghiyan K, et al. Association of wearable activity monitors with assessment of daily ambulation and length of stay among patients undergoing major surgery. JAMA Netw Open 2019;2:e187673. ArticlePubMedPMC
  • 19. Castelino T, Fiore JF Jr, Niculiseanu P, Landry T, Augustin B, Feldman LS. The effect of early mobilization protocols on postoperative outcomes following abdominal and thoracic surgery: a systematic review. Surgery 2016;159:991–1003. ArticlePubMed
  • 20. Krell RW, Girotti ME, Dimick JB. Extended length of stay after surgery: complications, inefficient practice, or sick patients? JAMA Surg 2014;149:815–20. ArticlePubMedPMC
  • 21. Hua R, Carter M, O'Brien MK, Pitt JB, Kwon S, Manworren RC, et al. Biorhythms derived from consumer wearables predict postoperative complications in children. Sci Adv 2025;11:eadv2643. ArticlePubMedPMC

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      • Cite this Article
        Cite this Article
        export Copy Download
        Close
        Download Citation
        Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

        Format:
        • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
        • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
        Include:
        • Citation for the content below
        Wearable-measured early postoperative mobility is associated with recovery after elective colorectal cancer surgery: a prospective pilot study
        Ann Coloproctol. 2026;42(5):553-560.   Published online October 27, 2026
        Close
      • XML DownloadXML Download
      Figure
      • 0
      • 1
      • 2
      Related articles
      Wearable-measured early postoperative mobility is associated with recovery after elective colorectal cancer surgery: a prospective pilot study
      Image Image Image
      Fig. 1. Study flow diagram of patient enrollment, postoperative wearable data collection, and final group allocation. POD, postoperative day.
      Fig. 2. Early postoperative step counts and discharge eligibility by postoperative day (POD) 3. Proportion of patients achieving Enhanced Recovery After Surgery (ERAS)-based discharge eligibility by POD 3 according to early postoperative mobility (POD 1–2 cumulative steps: active group, ≥3,781 steps; inactive group, <3,781). The P-value was calculated using the chi-square test.
      Graphical abstract
      Wearable-measured early postoperative mobility is associated with recovery after elective colorectal cancer surgery: a prospective pilot study
      Characteristic Active group (n=19) Inactive group (n=19) P-value
      Age (yr) 58 (24–81) 66 (45–73) 0.125
      Sex >0.999
       Male 13 (68.4) 13 (68.4)
       Female 6 (31.6) 6 (31.6)
      BMI (kg/m2) 0.295
       ≤25 11 (57.9) 15 (78.9)
       >25 8 (42.1) 4 (21.1)
      ASA physical status >0.999
       Ⅰ 2 (10.5) 2 (10.5)
       Ⅱ 15 (78.9) 15 (78.9)
       Ⅲ 2 (10.5) 2 (10.5)
      Tumor location 0.719
       Right-sided colon 4 (21.1) 5 (26.3)
       Left-sided colon 10 (52.6) 11 (57.9)
       Rectum 5 (26.3) 3 (15.8)
      Surgical approach 0.368
       Laparoscopic 18 (94.7) 18 (94.7)
       Open 0 (0) 1 (5.3)
       Conversion to open 1 (5.3) 0 (0)
      Procedure type 0.699
       Right hemicolectomy 4 (21.1) 3 (15.8)
       Transverse colectomy 0 1 (5.3)
       Left hemicolectomy 1 (5.3) 2 (10.5)
       Anterior resection 7 (36.8) 9 (47.4)
       Low anterior resection 5 (26.3) 4 (21.1)
       Ultralow anterior resection 1 (5.3) 0 (0)
       Abdominoperineal resection 1 (5.3) 0 (0)
      Pathological stage 0.598
       Ⅰ 6 (31.6) 6 (31.6)
       Ⅱ 3 (15.8) 5 (26.3)
       Ⅲ 5 (26.3) 6 (31.6)
       Ⅳ 5 (26.3) 2 (10.5)
      Postoperative complication 3 (15.8) 4 (21.1) >0.999
       Ileus 2 (10.5) 1 (5.3)
       Urinary complication 1 (5.3) 1 (5.3)
       Wound complication 0 (0) 1 (5.3)
       Fluid collection 0 (0) 1 (5.3)
      Time to passage of flatus or stool (day) 1 (1–3) 2 (1–4) 0.581
      Readmission 1 (5.3) 0 (0) >0.999
      Active group (n=19) Inactive group (n=19) P-value
      Discharge eligibility (day) 3 (2–7) 4 (3–16) 0.003
       Within POD 2 2 (10.5) 0 (0) 0.486
       Within POD 3 13 (68.4) 5 (26.3) 0.009
       Within POD 4 17 (89.5) 11 (57.9) 0.062
       Within POD 5 18 (94.7) 13 (68.4) 0.090
      Postoperative length of stay (day) 5 (4–8) 6 (4–16) 0.041
      Variable Adjusted OR (95% CI) P-value
      Active group (vs. inactive group) 5.55 (1.23–25.02) 0.026
      Age (per 1-yr increase) 0.98 (0.90–1.06) 0.577
      Sex (male vs. female) 1.04 (0.20–5.35) 0.959
      BMI (>25 kg/m2 vs. ≤25 kg/m2) 1.94 (0.37–10.30) 0.436
      ASA physical status (III vs. I–II) 5.12 (0.31–84.83) 0.254
      Discharge eligibility criteria No. of patients (%) P-value
      Active group (n=19) Inactive group (n=19)
      Afebrile status 0 (0) 3 (15.8) 0.230
      Tolerance of diet 2 (10.5) 10 (52.6) 0.013
      Absence of nausea or vomiting 0 (0) 4 (21.1) 0.105
      Passage of flatus or stool 0 (0) 1 (5.3) >0.999
      Ambulation for at least 1 hr per day 0 (0) 1 (5.3) >0.999
      Absence of surgical site infection 0 (0) 1 (5.3) >0.999
      Adequate pain control (NRS <4) 3 (15.8) 6 (31.6) 0.447
      Absence of surgery-related complications 1 (5.3) 4 (21.1) 0.340
      Table 1. Clinicopathological characteristics according to early postoperative step counts (n=38)

      Values are presented as number (%) or median (range).

      BMI, body mass index; ASA, American Society of Anesthesiologists.

      Table 2. Association between cumulative step count on PODs 1 and 2 measured using a wearable device and discharge eligibility (n=38)

      Values are presented as observed median (range) or number (%). The P-value for time to discharge readiness was calculated using the Mann-Whitney U-test. All 38 patients achieved discharge readiness during the observation period; no observations were censored.

      POD, postoperative day.

      Table 3. Multivariable logistic regression analysis for ERAS-based discharge eligibility by POD 3

      ERAS, Enhanced Recovery After Surgery; POD, postoperative day; BMI, body mass index; ASA, American Society of Anesthesiologists.

      Table 4. Comparison of individual unmet ERAS-based discharge criteria by POD 3 between active and inactive groups (n=38)

      ERAS, Enhanced Recovery After Surgery; POD, postoperative day; NRS, numeric rating scale.


      Ann Coloproctol : Annals of Coloproctology Twitter Facebook
      TOP